•  
  •  
  •  
  •  

2025-06-17 23:01:16

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • UGRO Capital Ltd to acquire 100% stake in Profectus Capital Pvt Ltd
  • Bihar CM Nitish Kumar inaugurates Bhupatipur-Punpun elevated road, built by Afcons
  • Equity Shares of Indosolar Ltd to list in NSE and BSE from June 19, 2025
  • ITCONS E-Solutions Limited receives new work orders from HCL Technologies Ltd

Keywords Selected:  USA

Research

  • 45% of Newbie traders claim that 'not knowing enough' is the primary reason for losses incurred in Futures & Options trading - Sharekhan's survey reveals
  • Domestic primary aluminium manufacturing entities are behind the curve in the transition to a greener future: ICRA
  • Campus Activewear - IPO - Strong Business Model, but Valuation is Stretched

Stock Report

  • Campus Activewear hosts largest-ever distributor meet - Shoecase 2025
  • Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
  • Strides acquires identified ANDAs from Nostrum Laboratories, Inc., USA
  • Jet Freight Logistics Ltd becomes India's First Airbus A330 P2F Widebody Cargo Airline Operator
  • Sonata Software Secures a $73 Million AI-led Digital Modernization Deal with a Leading US TMT Company
  • Himalaya Food International Ltd enters into MoU with Food Processor Cooperative of the US
  • Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery
  • Glenmark Pharmaceuticals Inc., USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
  • Bliss GVS Pharma Ltd's partner gets final approval from USFDA for Mesalamine Suppositories 1000 mg
  • Global Surfaces facility in the UAE to benefit from new tariffs imposed by USA
  • SPML Infra Powers into India's Next Big Energy Revolution with Grid-Scale BESS Rollout in Exclusive Collaboration with Energy Vault
  • Glenmark Pharmaceuticals Inc., USA launches Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-Dose Vial)
  • Arrow Greentech Ltd announces Grant of 'Dual-Color Shift Security Film' Patent in the United States of America
  • Wipro announces AI Agent Solutions across the Healthcare Industry Powered by Agentforce
  • Polyplex USA LLC commissions trial runs of two projects
  • Prince Pipes Commences Commercial Production at Begusarai, Bihar
  • Welspun Corp Limited receives new orders of approx. Rs. 2400 crores
  • Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease
  • Glenmark Therapeutics Inc., USA launches Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful - OTC
  • NIIT USA Inc invests $1 Mn in StriVR Labs Inc., USA
  • Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
  • USFDA classifies Aurobindo Pharma Inc's warehouse as OAI
  • Netweb Technologies Introduces Skylus.ai: Simplified and Easy Way to Set up a GPU-based AI Lab infrastructure

Industry News

  • LiaPlus AI raises INR 2 Crore in Seed Round led by Inflection Point Ventures

Latest Post

  • Rachit Prints Limited receives in-principle approval from BSE SME Exchange, Plans to Raise ₹19.50 Crore
  • UGRO Capital Ltd to acquire 100% stake in Profectus Capital Pvt Ltd
  • Bihar CM Nitish Kumar inaugurates Bhupatipur-Punpun elevated road, built by Afcons
  • Equity Shares of Indosolar Ltd to list in NSE and BSE from June 19, 2025
  • ITCONS E-Solutions Limited receives new work orders from HCL Technologies Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024